Robbins LLP reminds investors that a securities class action has been filed on behalf of investors who purchased or otherwise acquired Regeneron ...

Combined company plans to advance nebokitug, a first-in-class anti-CCL24 antibody, through a precision medicine Phase 2 trial in rheumatoid arthritis (RA) by leveraging Scipher’s AI Network Medicine ...

Discusses Update and Growth Initiatives for Araxa Niobium and Rare Earths Project in Brazil July 21, 2026 9:00 ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Michael is a former senior editor of investing and trading products for ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. When preparing for a ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. Passing the Architect ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. Your CFP® prep course ...

Researchers engineered “gyromorphs,” a new type of metamaterial that combines liquid-like randomness with large-scale structural patterns to block light from every direction. This innovation solves ...

Fox News senior medical analyst Dr. Marc Siegel analyzes new research from the New York Times, suggesting that adults may not need exactly eight hours of sleep. Trump's latest name for GLP-1s has ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. Choosing the wrong CIA ...

Drivers traveling through downtown Washington, D.C., in the coming days will begin seeing more than fresh pavement and ...